Gene · 683
Papers2,228
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,228
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Case Study of Dysfunctional Nicotinamide Metabolism in a 20-Year-Old Male. | Metabolites | 2023 | 36984839 | PubTator, text mining | PubMed |
| Endothelial Progenitor Cells Promote Osteosarcoma Progression and Invasiveness via AKT/PI3K Signaling. | Cancers (Basel) | 2023 | 36980704 | PubTator, text mining | PubMed |
| From birth to death: The hardworking life of Paneth cell in the small intestine. | Front Immunol | 2023 | 36969191 | PubTator, text mining | PubMed |
| Plant and prokaryotic TIR domains generate distinct cyclic ADPR NADase products. | Sci Adv | 2023 | 36930706 | PubTator, text mining | PubMed |
| Quantitative and causal analysis for inflammatory genes and the risk of Parkinson's disease. | Front Immunol | 2023 | 36926335 | PubTator, text mining | PubMed |
| Biochemical Origin of the Warburg Effect in Light of 15 Years of Research Experience: A Novel Evidence-Based View (An Expert Opinion Article). | Onco Targets Ther | 2023 | 36911533 | PubTator, text mining | PubMed |
| A Review of Genetic and Gene Therapy for Parkinson's Disease. | Cureus | 2023 | 36909056 | PubTator, text mining | PubMed |
| The autophagy-NAD axis in longevity and disease. | Trends Cell Biol | 2023 | 36878731 | PubTator, text mining | PubMed |
| Lymphoid stromal cells - potential implications for the pathogenesis of CVID. | Front Immunol | 2023 | 36875120 | PubTator, text mining | PubMed |
| NADases as weapons for both plant pathogens and their hosts. | Proc Natl Acad Sci U S A | 2023 | 36848576 | PubTator, text mining | PubMed |
| Anticancer Activities of Novel Nicotinamide Phosphoribosyltransferase Inhibitors in Hematological Malignancies. | Molecules | 2023 | 36838885 | PubTator, text mining | PubMed |
| Enzymology of Ca2+-Mobilizing Second Messengers Derived from NAD: From NAD Glycohydrolases to (Dual) NADPH Oxidases. | Cells | 2023 | 36831342 | PubTator, text mining | PubMed |
| CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD+-Lowering Agents. | Antioxidants (Basel) | 2023 | 36830052 | PubTator, text mining | PubMed |
| Accumulated precursors of specific GPI-anchored proteins upregulate GPI biosynthesis with ARV1. | J Cell Biol | 2023 | 36828365 | PubTator, text mining | PubMed |
| Development of prognostic indicator based on NAD+ metabolism related genes in glioma. | Front Surg | 2023 | 36778644 | PubTator, text mining | PubMed |
| The Central Role of the NAD+ Molecule in the Development of Aging and the Prevention of Chronic Age-Related Diseases: Strategies for NAD+ Modulation. | Int J Mol Sci | 2023 | 36769283 | PubTator, text mining | PubMed |
| SOMAscan Proteomics Identifies Novel Plasma Proteins in Amyotrophic Lateral Sclerosis Patients. | Int J Mol Sci | 2023 | 36768220 | PubTator, text mining | PubMed |
| Nicotinaldehyde, a Novel Precursor of NAD Biosynthesis, Abrogates the Anti-Cancer Activity of an NAD-Lowering Agent in Leukemia. | Cancers (Basel) | 2023 | 36765744 | PubTator, text mining | PubMed |
| Antibody therapies for the treatment of acute myeloid leukemia: exploring current and emerging therapeutic targets. | Expert Opin Investig Drugs | 2023 | 36762937 | PubTator, text mining | PubMed |
| Genome-wide association study using whole-genome sequencing identifies risk loci for Parkinson's disease in Chinese population. | NPJ Parkinsons Dis | 2023 | 36759515 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/683/papers?page=7